Network Driven Drug Discovery Using AI

by Andrii Buvailo        Biopharma insight / Video gallery

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or
Contributors are fully responsible for assuring they own any required copyright for any content they submit to This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

   5665    Comments 1

“One-target-one-disease” paradigm has been around for decades, prompting numerous drug discovery programs focusing on identifying small molecules for targeting only one specific protein (or other targets) believed to be responsible for the disease mechanism.

However, the limitations of such approach and the inability of “one-target-one-disease” way of thinking to comprehend the complexity of biological processes led an increasing interest in polypharmacology programs, multi-omics, and network biology.

One such company that is using network driven drug discovery approach is e-Therapeutics. Watch their recent video with an illustrative explanation of how understanding a bigger picture of cells and disease mechanisms can be a much more efficient way of creating better drugs. Since network driven drug discovery approach is a data-driven approach, the company uses artificial intelligence (AI) to efficiently deal with complex datasets.

Topics: Emerging Technologies    Biotech Companies   

Share this:              

You may also be interested to read:



  • Lana 2020-06-03 10:08

    Such a company doing a great job and i wish you all the best!


Leave a Reply

Your email address will not be published. Required fields are marked *

SHARE Share in Facebook Share in Twitter Share in LinkedIn Send by email